StockVS

Inflection Point Acquisition Corp IV (BACQU) 股票分析

金融服务

Inflection Point Acquisition Corp IV

$11.00

+$0.00 (+0.00%)

最后更新: 2026年3月16日

价格走势

分析

公司概述

Inflection Point Acquisition Corp IV operates within the financial services sector, specifically classified under the industry of shell companies, where its primary function involves effecting a merger, amalgamation, share exchange, asset acquisition, or share purchase. As of March 16, 2026, the entity was acquired by Merlin Labs, Inc., in a reverse merger transaction, and currently does not maintain any significant independent business operations prior to or following this consolidation. The company's market capitalization, price-to-book ratio, and annual revenue figures are currently unavailable or not applicable in standard financial reporting contexts, while the employee count is listed as N/A. These specific valuation metrics and scale indicators reflect the transitional nature of the company during the reverse merger process, where traditional market cap and revenue data often remain unreported or significantly altered during the acquisition phase, distinguishing it from mature operating entities with established revenue streams.

财务健康

The financial profile of Inflection Point Acquisition Corp IV shows a net income of $6.01 million for the trailing twelve months (TTM), while revenue and EBITDA figures are reported as N/A. The absence of reported revenue combined with a positive net income of $6.01 million suggests a non-traditional cost structure where income is generated without corresponding operating revenues, a characteristic typical of shell companies or entities in pre-operational merger stages. Free cash flow stands at $-583,318, indicating a net outflow of cash that impacts the company's immediate financial flexibility and liquidity management during the transition period. All three margin metrics—gross margin, operating margin, and profit margin—are recorded at 0.0%, which indicates that the company has not yet generated revenue or is operating in a manner where these traditional profitability ratios do not apply to its current business model. On the balance sheet, the company holds $703,596 in cash against $0 in debt, resulting in a debt-to-equity ratio that is listed as N/A, which points to a highly conservative leverage position with no outstanding obligations. However, the current ratio is reported at 0.27, a figure that suggests limited short-term liquidity relative to current liabilities, a common state for special purpose acquisition companies (SPACs) before or immediately after a merger. Return on Equity and Return on Assets are both unavailable or not applicable, with the Return on Assets specifically noted as -1.1%, revealing that the management's effectiveness in generating returns on the company's assets is currently negative or undefined due to the lack of operational scale.

估值评估

Trailing P/E and forward P/E ratios are both listed as N/A, which implies that standard valuation models based on earnings multiples cannot be applied to derive an expected earnings trajectory for this specific entity at this time. The price-to-book ratio is recorded at -33.23, a negative figure that indicates the market valuation is detached from tangible book value, a phenomenon often seen in shell companies or firms with significant intangible assets or restructuring costs rather than a standard market premium over book value. Alternative valuation metrics such as price-to-sales ratio and EV/EBITDA are also N/A, suggesting that these conventional measures are not relevant for assessing the company's current valuation multiple during its acquisition phase. The stock's 52-week high was $13.97 and the 52-week low was $10.14, providing a trading range within which the current price fluctuates, though the exact current price relative to this specific range cannot be calculated without a real-time stock quote. The beta value is listed as N/A, meaning that the company's price volatility relative to the broader market cannot be quantified using standard regression analysis against the market index at this time.

Growth & Income

Revenue growth year-over-year and earnings growth year-over-year are both reported as N/A, indicating that historical growth rates are not applicable or available for a company undergoing a reverse merger transaction. Since the company does not pay a dividend, with a dividend yield and payout ratio both listed as N/A, the entity reinvests its available earnings and cash reserves into growth initiatives such as completing the merger with Merlin Labs, Inc. rather than distributing income to shareholders. The lack of reported revenue growth and the specific classification of the business description confirm that the company's profile is defined by its acquisition status rather than organic growth metrics. In summary, the overall growth and income profile is characterized by the absence of traditional financial growth data and dividend payouts, reflecting the transitional status of the company as it integrates into a larger operational entity.

同行比较

Inflection Point Acquisition Corp IV (BACQU) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Inflection Point Acquisition Corp IV BACQU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Inflection Point Acquisition Corp IV的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Inflection Point Acquisition Corp IV

As of March 16, 2026, Inflection Point Acquisition Corp. IV was acquired by Merlin Labs, Inc., in a reverse merger transaction. Inflection Point Acquisition Corp. IV does not have any significant business. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was formerly known as Bleichroeder Acquisition Corp. I and change its name to Inflection Point Acquisition Corp. IV in October 2025. Inflection Point Acquisition Corp. IV was incorporated in 2024 and is based in New York, New York.

公司简介以英文显示。

关键指标

市值
N/A
市盈率
N/A
52周最高
$13.97
52周最低
$10.14
平均成交量
98

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States